Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: SICAV
  • Objective: US
  • Asset Class: Equity
  • Geographic Focus: U.S.

Candriam Quant Equities USA

+ Add to Watchlist

DEXQUED:LX

2,129.83 USD 2.19 0.10%

As of 00:59:30 ET on 03/26/2015.

Snapshot for Candriam Quant Equities USA (DEXQUED)

Year To Date: -0.11% 3-Month: -1.37% 3-Year: +11.99% 52-Week Range: 1,929.13 - 2,198.41
1-Month: -2.85% 1-Year: +9.12% 5-Year: +12.28% Beta vs SPX: 1.02

Mutual Fund Chart for DEXQUED

No chart data available.
  • DEXQUED:LX 2,129.83
  • 1M
  • 1Y
Interactive DEXQUED Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for DEXQUED

Candriam Quant - Equities USA is a SICAV incorporated under the laws of Luxembourg. The Fund's objective is capital appreciation. The Fund invests at least two-thirds of its assets in U.S. equities. The Fund may also invest in warrants, liquidities and money-market instruments.

Inception Date: 03-27-2003 Telephone: 352-254-3431
Managers: ERWIN DE WINTER
Web Site: www.candriam.com

Fundamentals for DEXQUED

NAV (on 2015-03-26) 2,129.83
Assets (M) (on 2015-03-26) 1,330.30
Fund Leveraged N
Minimum Investment -
Minimum Subsequent Investment -

Dividends for DEXQUED

Dividend Type Income
Dividend Frequency Annual
Last Dividend Net (on 2014-04-29) 23.00
Dividend Yield (ttm) 1.08

Fees & Expenses for DEXQUED

Front Load 3.50
Back Load 0.00
Current Mgmt Fee 1.50
Redemption Fee 0.00
12b1 Fee -
Expense Ratio 1.81

Top Fund Holdings for DEXQUED

Filing Date: 01/30/2015
Name Position Value % of Total
Apple Inc 285,818 33,486,437 2.595%
Berkshire Hathaway Inc 175,913 25,315,640 1.962%
Facebook Inc 319,654 24,264,935 1.880%
Merck & Co Inc 399,838 24,102,235 1.868%
Coca-Cola Co/The 573,644 23,616,923 1.830%
Visa Inc 339,576 21,640,330 1.677%
Philip Morris International In 255,869 20,530,929 1.591%
QUALCOMM Inc 309,154 19,309,759 1.496%
Electronic Arts Inc 324,700 17,813,042 1.380%
Pfizer Inc 559,124 17,472,625 1.354%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil